Gabriel Plotkin Exact Sciences Corp Transaction History
Melvin Capital Management LP
- $0
- Q3 2023
A detailed history of Gabriel Plotkin (Melvin Capital Management LP) transactions in Exact Sciences Corp stock. As of the latest transaction made, Melvin Capital Management LP holds 200,000 shares of EXAS stock, worth $11.9 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$11.9 Million% of portfolio
0.08%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding EXAS
# of Institutions
673Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.06 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$941 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$851 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$717 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$397 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.5B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...